Author

S. Smieszek

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

B. Przychodzen· 1 shared M. H. Polymeropoulos· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

2 top collaborators · 1 mutual co-author link

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

B. Przychodzen

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MicrobiologybioRxivPreprintApr 5, 2020

Amantadine disrupts lysosomal gene expression; potential therapy for COVID19

S. Smieszek, B. Przychodzen, M. H. Polymeropoulos

This study identifies amantadine as a compound that downregulates CTSL/CTSB gene expression and disrupts the lysosomal pathway, potentially inhibiting SARS-CoV-2 replication.

DOI 10.1101/2020.04.05.026187

humanbulk RNA-seq

𝕏 PostBluesky